<DOC>
	<DOCNO>NCT02250469</DOCNO>
	<brief_summary>12-SMI-2014 post-market , randomise , pilot study identify rate difference patient experience two different type Spinal Cord Stimulator device routinely use treat chronic pain .</brief_summary>
	<brief_title>A Randomised Pilot Study Assess Differences Stimulation Induced Paresthesia Between 2 Spinal Cord Stimulation Systems</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Paresthesia</mesh_term>
	<criteria>1 . Subject appropriate SCS implantation accord standard criterion 2 . Subject &gt; 18 &lt; 75 year old 3 . Subject able willing comply followup schedule protocol 4 . Subject chronic ( &gt; 6 month ) uni/bilateral neuropathic pain low limb ( ) ( knee ) predominant foot pain 5 . Minimum baseline pain rating 50 mm VAS primary region pain 6 . Subject able provide write informed consent 1 . Subject exclusion criterion SCS implantation accord standard criterion 2 . Subject corticosteroid therapy intend site stimulation within past 30 day 3 . Subject radiofrequency treatment intend target DRG within past 3 month 4 . Subject participate another clinical study within 30 day 5 . Subject previously treat fail respond implantable neuromodulation therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>